The stake sale found buyers, with a clutch of domestic and foreign institutional investors participating in the transaction.

Cyril Amarchand Mangaldas acted as the Indian legal counsel to J.P. Morgan India Private Limited with respect to the sale of equity shares of Meesho Limited by SVF II Meerkat (DE) LLC, undertaken on the floor of NSE on September 3, 2026 for an aggregate consideration of Rs. 1,650 crores (approx).

SoftBank Vision Fund entity SVF II Meerkat (DE) LLC sold around 80 million equity shares of Meesho Ltd, representing 1.5% of the company’s existing share capital, through a bulk deal on the stock exchanges. 

After the transaction, SoftBank's holding in Meesho declined to 6.87 per cent from 8.6 per cent.

The stake sale, however, found buyers, with a clutch of domestic and foreign institutional investors participating in the transaction.

Mutual Funds managed by Motilal Oswal, Franklin Templeton, Canara Robeco, and HSBC, along with HDFC Standard Life Insurance and Bajaj Life Insurance Company, were among the domestic institutional investors that picked up Meesho shares at the same price. Foreign investors that participated in the transaction included Fidelity, Goldman Sachs, Manulife Singapore, Government Pension Fund of Norway, Copthall Mauritius, BofA Securities, Dendana Investments Mauritius, Ghisallo Capital Management, Morgan Stanley and Kuwait Investment Authority.

BofA Securities India and J.P. Morgan India are acting as placement agents for the 100% secondary sale. The vendor, its agents, nominees and affiliates will be subject to a 60-day lock-up following the transaction.

The transaction was led by Aashima Johur, Partner; with support from Medhashree Verma, Senior Associate.

Tags: